XML 48 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Basic EPS        
Net earnings attributable to AbbVie Inc. $ 1,778 $ 3,949 $ 4,041 $ 9,363
Earnings allocated to participating securities 11 18 32 43
Earnings available to common shareholders $ 1,767 $ 3,931 $ 4,009 $ 9,320
Weighted-average basic shares outstanding (in shares) 1,767 1,771 1,768 1,771
Basic earnings per share (in dollars per share) $ 1.00 $ 2.22 $ 2.27 $ 5.26
Diluted EPS        
Net earnings attributable to AbbVie Inc. $ 1,778 $ 3,949 $ 4,041 $ 9,363
Earnings allocated to participating securities 11 18 32 43
Earnings available to common shareholders $ 1,767 $ 3,931 $ 4,009 $ 9,320
Weighted-average basic shares outstanding (in shares) 1,767 1,771 1,768 1,771
Effect of dilutive securities (in shares) 4 5 4 6
Weighted-average diluted shares outstanding (in shares) 1,771 1,776 1,772 1,777
Diluted earnings per share (in dollars per share) $ 1.00 $ 2.21 $ 2.26 $ 5.24